FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:DPP8-TRPM1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: DPP8-TRPM1
FusionPDB ID: 24043
FusionGDB2.0 ID: 24043
HgeneTgene
Gene symbol

DPP8

TRPM1

Gene ID

54878

4308

Gene namedipeptidyl peptidase 8transient receptor potential cation channel subfamily M member 1
SynonymsDP8|DPRP-1|DPRP1|MST097|MSTP097|MSTP135|MSTP141CSNB1C|LTRPC1|MLSN1
Cytomap

15q22.31

15q13.3

Type of geneprotein-codingprotein-coding
Descriptiondipeptidyl peptidase 8DPP VIIIdipeptidyl peptidase IV-related protein 1dipeptidyl peptidase VIIIprolyl dipeptidase DPP8transient receptor potential cation channel subfamily M member 1long transient receptor potential channel 1melastatin-1transient receptor potential melastatin family
Modification date2020031320200313
UniProtAcc

Q6V1X1

Main function of 5'-partner protein: FUNCTION: Dipeptidyl peptidase that cleaves off N-terminal dipeptides from proteins having a Pro or Ala residue at position 2. {ECO:0000269|PubMed:11012666, ECO:0000269|PubMed:12534281, ECO:0000269|PubMed:12662155, ECO:0000269|PubMed:15039077, ECO:0000269|PubMed:15664838, ECO:0000269|PubMed:20536396, ECO:0000305|PubMed:29382749}.
.
Ensembl transtripts involved in fusion geneENST idsENST00000300141, ENST00000321118, 
ENST00000321147, ENST00000341861, 
ENST00000358939, ENST00000559233, 
ENST00000339244, ENST00000560048, 
ENST00000559179, ENST00000256552, 
ENST00000397795, ENST00000542188, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score7 X 7 X 4=1965 X 4 X 4=80
# samples 86
** MAII scorelog2(8/196*10)=-1.29278174922785
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(6/80*10)=-0.415037499278844
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: DPP8 [Title/Abstract] AND TRPM1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: DPP8 [Title/Abstract] AND TRPM1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)DPP8(65766547)-TRPM1(31327877), # samples:1
Anticipated loss of major functional domain due to fusion event.DPP8-TRPM1 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF.
DPP8-TRPM1 seems lost the major protein functional domain in Hgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
DPP8-TRPM1 seems lost the major protein functional domain in Tgene partner, which is a IUPHAR drug target due to the frame-shifted ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneTRPM1

GO:0060402

calcium ion transport into cytosol

23452348



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr15:65766547/chr15:31327877)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across DPP8 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across TRPM1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000341861DPP8chr1565766547-ENST00000397795TRPM1chr1531327877-62333165158154711296
ENST00000341861DPP8chr1565766547-ENST00000256552TRPM1chr1531327877-59603165158154711296
ENST00000341861DPP8chr1565766547-ENST00000542188TRPM1chr1531327877-59443165158154711296
ENST00000559233DPP8chr1565766547-ENST00000397795TRPM1chr1531327877-4764169611240021296
ENST00000559233DPP8chr1565766547-ENST00000256552TRPM1chr1531327877-4491169611240021296
ENST00000559233DPP8chr1565766547-ENST00000542188TRPM1chr1531327877-4475169611240021296

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000341861ENST00000397795DPP8chr1565766547-TRPM1chr1531327877-0.0032336690.9967663
ENST00000341861ENST00000256552DPP8chr1565766547-TRPM1chr1531327877-0.0037727620.99622726
ENST00000341861ENST00000542188DPP8chr1565766547-TRPM1chr1531327877-0.0038975390.99610245
ENST00000559233ENST00000397795DPP8chr1565766547-TRPM1chr1531327877-0.0010227640.9989773
ENST00000559233ENST00000256552DPP8chr1565766547-TRPM1chr1531327877-0.0015841620.9984158
ENST00000559233ENST00000542188DPP8chr1565766547-TRPM1chr1531327877-0.0017019720.998298

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for DPP8-TRPM1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
DPP8chr1565766547TRPM1chr15313278771696528SGEWEVLGRHGSNISYLGYLLLFNYV
DPP8chr1565766547TRPM1chr15313278773165528SGEWEVLGRHGSNISYLGYLLLFNYV

Top

Potential FusionNeoAntigen Information of DPP8-TRPM1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
DPP8-TRPM1_65766547_31327877.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:18RHGSNISY0.81890.6853816
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:02GRHGSNISY0.99880.7132716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:04GRHGSNISY0.99880.7957716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:05GRHGSNISY0.99870.9319716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B39:01RHGSNISYL0.99360.7824817
DPP8-TRPM1chr1565766547chr15313278773165HLA-B38:02RHGSNISYL0.980.8814817
DPP8-TRPM1chr1565766547chr15313278773165HLA-B38:01RHGSNISYL0.97880.8759817
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:17GSNISYLGY0.94630.60211019
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:10RHGSNISYL0.7440.5593817
DPP8-TRPM1chr1565766547chr15313278773165HLA-B47:01GRHGSNISY0.56350.551716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:03GRHGSNISY0.37140.739716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:18GRHGSNISY0.3590.6993716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:37RHGSNISYL0.22870.5118817
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:02GRHGSNISYL0.99970.6805717
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:05GRHGSNISYL0.99960.9249717
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:04GRHGSNISYL0.99960.7849717
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:04LGRHGSNISY0.98890.8092616
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:02LGRHGSNISY0.9880.7456616
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:18LGRHGSNISY0.90230.7293616
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:01VLGRHGSNISY0.99960.9207516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:02VLGRHGSNISY0.9940.7533516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:05VLGRHGSNISY0.99360.94516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:04VLGRHGSNISY0.98970.8293516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:25VLGRHGSNISY0.98870.9369516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:02VLGRHGSNISY0.97590.9397516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:14GRHGSNISY0.99570.827716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:03GRHGSNISY0.98980.9438716
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:95GRHGSNISY0.98380.6296716
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:27GRHGSNISY0.97980.942716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B39:05RHGSNISYL0.96790.7549817
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:05GRHGSNISY0.96040.9455716
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:19GRHGSNISY0.91270.5988716
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:46GRHGSNISY0.86110.8209716
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:67GRHGSNISY0.85260.909716
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:80GRHGSNISY0.85260.909716
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:10GRHGSNISY0.85060.9183716
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:13RHGSNISYL0.7430.9028817
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:29RHGSNISYL0.73610.9361817
DPP8-TRPM1chr1565766547chr15313278773165HLA-C15:04GSNISYLGY0.52460.69661019
DPP8-TRPM1chr1565766547chr15313278773165HLA-C12:16GRHGSNISY0.0950.937716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:14GRHGSNISYL0.99970.8371717
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:03GRHGSNISYL0.99430.9401717
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:03LGRHGSNISY0.86390.9478616
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:07VLGRHGSNISY0.9990.5634516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:03VLGRHGSNISY0.8790.9502516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:05VLGRHGSNISY0.87770.9019516
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:46VLGRHGSNISY0.6890.9112516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:08GRHGSNISY0.99860.8258716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:10GRHGSNISY0.99860.9027716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:06GRHGSNISY0.99230.7871716
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:01GRHGSNISY0.99130.6066716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B38:05RHGSNISYL0.97880.8759817
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:17GRHGSNISY0.94860.9448716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:09GRHGSNISY0.94340.9099716
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:02GRHGSNISY0.85260.909716
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:22GRHGSNISY0.79580.656716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:09RHGSNISYL0.57560.5636817
DPP8-TRPM1chr1565766547chr15313278773165HLA-C15:09GSNISYLGY0.52460.69661019
DPP8-TRPM1chr1565766547chr15313278773165HLA-B39:11RHGSNISYL0.50260.6563817
DPP8-TRPM1chr1565766547chr15313278773165HLA-C06:08GRHGSNISY0.47310.9891716
DPP8-TRPM1chr1565766547chr15313278773165HLA-C07:04RHGSNISYL0.33660.8634817
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:53GRHGSNISY0.32750.8624716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B48:02GRHGSNISY0.26140.8985716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:54GRHGSNISY0.17090.8362716
DPP8-TRPM1chr1565766547chr15313278773165HLA-C06:06RHGSNISYL0.11640.989817
DPP8-TRPM1chr1565766547chr15313278773165HLA-C06:17GRHGSNISY0.01550.9871716
DPP8-TRPM1chr1565766547chr15313278773165HLA-C06:02GRHGSNISY0.01550.9871716
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:08GRHGSNISYL0.99960.821717
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:10GRHGSNISYL0.99950.9015717
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:06GRHGSNISYL0.99910.7462717
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:09GRHGSNISYL0.99880.8941717
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:10LGRHGSNISY0.98930.9105616
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:08LGRHGSNISY0.98650.8528616
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:68LGRHGSNISY0.95890.5092616
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:34VLGRHGSNISY0.99960.9207516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:125VLGRHGSNISY0.99960.9207516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:33VLGRHGSNISY0.99960.9207516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:27VLGRHGSNISY0.99960.9324516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:135VLGRHGSNISY0.99960.9364516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:50VLGRHGSNISY0.99950.9638516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:12VLGRHGSNISY0.99910.9468516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:35VLGRHGSNISY0.99890.8993516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:10VLGRHGSNISY0.99130.9247516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B27:08VLGRHGSNISY0.98980.8594516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:39VLGRHGSNISY0.98740.8561516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:68VLGRHGSNISY0.97440.5135516
DPP8-TRPM1chr1565766547chr15313278773165HLA-B15:20VLGRHGSNISY0.88560.9374516

Top

Potential FusionNeoAntigen Information of DPP8-TRPM1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
DPP8-TRPM1_65766547_31327877.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)
DPP8-TRPM1chr1565766547chr15313278773165DRB1-0801SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-0802SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-0805SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-0808SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-0809SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-0811SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-0813SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-0815SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-0816SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-0821SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-0824SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-0824GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-0826SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-0830SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-0839SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1101SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1101GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1105SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1105GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1108SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1108GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1109SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1109GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1110SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1110GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1111SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1112SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1112GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1115SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1115GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1119SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1124SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1124GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1127SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1127GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1128SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1128GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1129SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1129GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1130SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1131SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1132SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1132GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1133SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1133GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1137SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1137GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1139SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1139GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1145SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1149SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1149GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1151SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1151GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1161SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1161GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1162SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1162GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1164SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1166SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1166GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1168SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1169SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1172SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1172GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1173SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1174SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1174GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1175SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1175GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1180SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1180GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1181SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1181GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1182SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1187SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1187GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1190SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1190GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1191SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1191GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1193SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1193GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1194SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1194GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1195SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1195GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1196SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1196GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1305SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1305GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1307SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1307GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-13100SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1314SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1314GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1321SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1326SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1326GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1329SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1337SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1346SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1347SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1347GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1349SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1350SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1350GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1355SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1356SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1356GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1360SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1362SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1362GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1363SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1382SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1385SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1386SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1403SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1422SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1425SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1427SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1427GEWEVLGRHGSNISY116
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1430SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1440SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1453SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1467SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1469SGEWEVLGRHGSNIS015
DPP8-TRPM1chr1565766547chr15313278773165DRB1-1477SGEWEVLGRHGSNIS015

Top

Fusion breakpoint peptide structures of DPP8-TRPM1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
5025LGRHGSNISYLGYLDPP8TRPM1chr1565766547chr15313278773165

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of DPP8-TRPM1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN5025LGRHGSNISYLGYL-5.10891-5.11611
HLA-B52:013W395025LGRHGSNISYLGYL-3.96405-3.97125
HLA-A24:025HGA5025LGRHGSNISYLGYL-7.52386-7.53106
HLA-B44:053DX85025LGRHGSNISYLGYL-6.52848-6.53568

Top

Vaccine Design for the FusionNeoAntigens of DPP8-TRPM1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
DPP8-TRPM1chr1565766547chr15313278771019GSNISYLGYGGATCTAATATATCATACTTGGGCTAC
DPP8-TRPM1chr1565766547chr1531327877516VLGRHGSNISYGTTCTTGGCCGGCATGGATCTAATATATCATAC
DPP8-TRPM1chr1565766547chr1531327877616LGRHGSNISYCTTGGCCGGCATGGATCTAATATATCATAC
DPP8-TRPM1chr1565766547chr1531327877716GRHGSNISYGGCCGGCATGGATCTAATATATCATAC
DPP8-TRPM1chr1565766547chr1531327877717GRHGSNISYLGGCCGGCATGGATCTAATATATCATACTTG
DPP8-TRPM1chr1565766547chr1531327877816RHGSNISYCGGCATGGATCTAATATATCATAC
DPP8-TRPM1chr1565766547chr1531327877817RHGSNISYLCGGCATGGATCTAATATATCATACTTG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence
DPP8-TRPM1chr1565766547chr1531327877015SGEWEVLGRHGSNISAGTGGTGAATGGGAAGTTCTTGGCCGGCATGGATCTAATATATCA
DPP8-TRPM1chr1565766547chr1531327877116GEWEVLGRHGSNISYGGTGAATGGGAAGTTCTTGGCCGGCATGGATCTAATATATCATAC

Top

Information of the samples that have these potential fusion neoantigens of DPP8-TRPM1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
SARCDPP8-TRPM1chr1565766547ENST00000341861chr1531327877ENST00000256552TCGA-FX-A3TO-01A

Top

Potential target of CAR-T therapy development for DPP8-TRPM1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note
TgeneTRPM1chr15:65766547chr15:31327877ENST0000025655219281055_107501626.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST0000025655219281106_112601626.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST000002565521928898_91801626.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST000002565521928929_94901626.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST000002565521928962_98201626.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST0000039779518271055_107501604.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST0000039779518271106_112601604.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST000003977951827898_91801604.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST000003977951827929_94901604.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST000003977951827962_98201604.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST0000054218818271055_107501643.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST0000054218818271106_112601643.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST000005421881827898_91801643.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST000005421881827929_94901643.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST000005421881827962_98201643.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST00000559179031055_10750137.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST00000559179031106_11260137.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST0000055917903831_8510137.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST0000055917903898_9180137.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST0000055917903929_9490137.0TransmembraneHelical
TgeneTRPM1chr15:65766547chr15:31327877ENST0000055917903962_9820137.0TransmembraneHelical

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to DPP8-TRPM1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to DPP8-TRPM1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource